Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large B-Cell, Diffuse 2HIV Infections 2Epstein-Barr Virus Infections 2AIDS-Related Opportunistic Infections 2Wilms Tumor 1Testicular Neoplasms 1Stem Cell Transplant Complications 1Sezary Syndrome 1Salivary Gland Adenoma, Pleomorphic 1Recurrence 1Prostatic Neoplasms 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neuroblastoma 1Neoplasms 1Nasopharyngeal Carcinoma 1Myeloproliferative Disorders 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukoplakia, Oral 1Leukoplakia, Hairy 1Leukemia, Neutrophilic, Chronic 1Leukemia, Myelomonocytic, Juvenile 1

Interventions

Cisplatin 123Gemcitabine 70Radiotherapy, Intensity-Modulated 56toripalimab 39Capecitabine 36Fluorouracil 33Docetaxel 32Radiotherapy 24camrelizumab 23Drug Therapy 20nimotuzumab 18spartalizumab 13pembrolizumab 13nedaplatin 12apatinib 11Chemoradiotherapy 11tislelizumab 10sintilimab 10Nivolumab 10Magnetic Resonance Spectroscopy 10Induction Chemotherapy 10Immune Checkpoint Inhibitors 10Specimen Handling 9Cetuximab 9Carboplatin 9endostar protein 8Paclitaxel 8Bevacizumab 8anlotinib 7Radiation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Nasopharyngeal Carcinoma × Acyclovir × Clear all
NCT03656965 2018-09-04

EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug

Kuwait Cancer Control Center

Phase 3 Unknown
50 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡